Cargando…
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1
BACKGROUND: Lactate levels within tumors are correlated with metastases, tumor recurrence, and radioresistance, thus apparently contributing to poor outcomes in patients with various cancers. We previously reported that high-level production of lactate by multiple myeloma (MM) cell lines is associat...
Autores principales: | Fujiwara, Shiho, Wada, Naoko, Kawano, Yawara, Okuno, Yutaka, Kikukawa, Yoshitaka, Endo, Shinya, Nishimura, Nao, Ueno, Nina, Mitsuya, Hiroaki, Hata, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407384/ https://www.ncbi.nlm.nih.gov/pubmed/25909034 http://dx.doi.org/10.1186/s40164-015-0008-z |
Ejemplares similares
-
Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
por: KAWANO, YAWARA, et al.
Publicado: (2013) -
Bufalin induces DNA damage response under hypoxic condition in myeloma cells
por: Fujii, Eri, et al.
Publicado: (2018) -
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
por: WADA, NAOKO, et al.
Publicado: (2014) -
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
por: KAWANO, YAWARA, et al.
Publicado: (2012) -
PDK1 inhibition is a novel therapeutic target in multiple myeloma
por: Fujiwara, S, et al.
Publicado: (2013)